PATENT CLAIM ANALYSIS

Application Number: 15771845
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "263340"]

Abstract:
The invention discloses a crystal form A of a compound (I) and a preparation method thereof, and further discloses an application of the crystal form A as a PDE2 or TNF-α inhibitor.

Claim (Index 1):
A crystal form A of compound (I), the XRPD pattern of the crystal form A shows peaks in 2-Theta 9.578, 10.43, 12.502, 13.996, 15.086, 15.38, 16.287, 16.661, 17.428, 17.646, 18.298, 19.977, 20.427, 20.879, 21.314, 22.141, 22.928, 23.387, 24.27, 24.548, 25.116, 25.834, 26.719, 27.665, 29.477, 30.956, 32.416, 34.623, 37.243, 39.237.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 91.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15517951', '15575037', '15575315', '15512412', '12066813']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7206517793047666
- 35 USC 102 Novelty (BERT): 0.5272610034445907
- Combined Prediction Score: 0.701312701718749
- Mean Citation Score: 200.209468
- Max Citation Score: 257.63858
- Similarity Product: 142.4039642126548

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test